Search

A 55-year-old woman presented with a 3-year history of recurrent episodes of pruritic cellulitis-like erythematous plaques, mostly located on the limbs. Simultaneously, fever, malaise and peripheral eosinophilia were noted. The clinical diagnosis of eosinophilic cellulitis (also known as Well’s syndrome) was supported by the histopathological finding of typical “flame figures”. Treatment with dapsone was initiated at a dose of 50 mg per day. After one year of follow-up the patient was relapse-free. Eosinophilic cellulitis is an uncommon, recurrent inflammatory skin disease. The management is often a challenge, due to the frequent need for long-term therapy. Dapsone is an effective and safe treatment option.

Among the new applications of dermoscopy, five main fields can be distinguished: dermoscopy of skin infections and infestations (entomodermoscopy), inflammatory skin diseases (inflammoscopy), hair disorders (trichoscopy), nailfold cappilaries (capillaroscopy), and dermoscopy for treatment decisions or treatment monitoring. The term entomodermoscopy, from the words dermoscopy and entomology, has been introduced to describe the use of dermoscopy in the diagnosis of infectious skin disorders. Herein, we report several cases concerning its applicability in the diagnosis of molluscum contagiosum, scabies, lice infestations, viral warts and early cutaneous leishmaniasis. [ABSTRACT FROM AUTHOR]

Introduction: Relapse of Hansen's disease refers to the appearance of new signs and symptoms in patients with a previous diagnosis and who completed the treatment regimen proposed by WHO. Objectives: To determine and characterize relapse cases of Hansen's disease within five years (2008-2012), in Hansen's disease consultation from Hospital Curry Cabral. Material and Methods: We conducted a retrospective and descriptive review of clinical records, identifying cases in a total of 89 patients seen in consultation in that period. The minimum follow-up time was 6 months. In all cases, clinical suspicion of relapse was confirmed by bacteriological and histopathological examination. Results: We identified 4 cases of relapse, which corresponded to 4.5% of patients observed, all with a previous diagnosis of borderline lepromatous clinical form, according to the Ridley-Jopling classification. Therapy has been established for multibacillar forms according to WHO scheme in all cases. Relapses occurred in a follow-up period between 7 and 16 months after treatment discontinuation. Discussion: The frequency of relapse in this population was higher than that observed in most studies. There was poor adherence to therapy in all cases, admitted as the cause of relapse, after excluded other factors. We emphasize the importance of regular monitoring of patients undergoing treatment, to ensure adherence and effectiveness of therapy. [ABSTRACT FROM AUTHOR]